Gentian Diagnostics ASA (OSL:GENT)
Norway · Delayed Price · Currency is NOK 43.80
-0.60 (-1.35%)
Feb 23, 2026, 4:28 PM CET
Gentian Diagnostics ASA Market Cap
Gentian Diagnostics ASA has a market cap or net worth of 684.75 million as of February 23, 2026. Its market cap has decreased by -3.90% in one year.
Market Cap
684.75M
Enterprise Value
598.27M
Revenue
176.50M
Ranking
n/a
PE Ratio
51.66
Stock Price
43.80
Market Cap Chart
Since December 14, 2016, Gentian Diagnostics ASA's market cap has increased from 289.62M to 684.75M, an increase of 136.43%. That is a compound annual growth rate of 9.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 684.75M | -21.28% |
| Dec 30, 2025 | 869.82M | 43.88% |
| Dec 30, 2024 | 604.56M | -5.54% |
| Dec 29, 2023 | 640.03M | 1.22% |
| Dec 30, 2022 | 632.32M | -43.06% |
| Dec 30, 2021 | 1.11B | 32.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 3.82B |
| Nordhealth AS | 2.41B |
| Photocure ASA | 1.57B |
| Thor Medical ASA | 1.55B |
| Nykode Therapeutics AS | 1.17B |
| ArcticZymes Technologies ASA | 1.16B |
| Vistin Pharma ASA | 944.54M |
| Omda AS | 797.75M |